There is a lot of talk on the different biotech threads on HC about the next CSL or next COH. Clinuvel doesn't attract anywhere near the same sort of following and there are a number of reasons for this, however they continue to quietly and SLOWLY get on with the job.
Clinuvel is now a profitable company with a NDA submitted for a New Molecular Entity. The basic science for afamelanotide published in may hundreds of papers is well proven and the potential clinical applications could bring phenomenal wealth. It is very tightly held and easily manipulated but with only 50 million shares it will be discovered soon enough. One for the investors and not the speculators.
Well done Clinuvel
Ann: CLINUVEL completes SCENESSE FDA Filing, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $741.1M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
